China Pharma Holdings Inc.’s stock (NYSE:CPHI) has been rated as Mkt Outperform by Rodman & Renshaw. This latest rating was contained in a recent research note published by the firm on January 08, 2010 and has set a $6 price target for the stock. Some experts on Wall Street have also posted a report on China Pharma Holdings Inc. (CPHI) stock.
As it stands, a total of 1 analysts are covering CPHI stock, with 1 of them rating it as a Buy while 0 of them rating it as Overweight. 0 analysts meanwhile advised investors to Hold, 0 rated it as Underweight while the 0 rated it as a Sell. A look at the overall ratings means that China Pharma Holdings Inc. (CPHI) stock has an average rating of Buy.
China Pharma Holdings Inc. (CPHI) which is currently valued at 20.26 million. In recent quarter, China Pharma Holdings Inc. (CPHI) posted $0.15 earnings per share (EPS) which was below the analyst consensus estimate of $0.16 by -$0.01, which represents a decrease by -6.30%.
The stock market has a tendency to become sophisticated sometimes, even for seasoned investors and traders. Even when a trader got what he/she had expected, the market sometimes decides to move in the opposite direction. This volatility sometimes leads to some traders doubting and second-guessing their moves. This is why getting to know historical price performance, as well as both long-term and short-term trends, is very important. Over the past one week, CPHI price has surged by 23.36%. A look at its price performance over the past three months sees the stock go up by 102.30%, while it has gain 98.81% over the past six months and 73.63% since the start of the year.
Let us now look at some of its likely support and resistance level. Recent research on China Pharma Holdings Inc. (CPHI) has seen its stock trading -45.89% below its three-month high price. A look at the other side also sees stock trading +144.27% above its three-month low. A wider look sees CPHI trading -45.89% below its 52-week high and 144.27% above from its 52-week low price.
Shareholders of the company sometimes like to find out how their investments are growing. China Pharma Holdings Inc. (CPHI) has so far given an ROE of -32.60%. When the ROE is low, it means that the company isn’t generating enough profits. The Return on Assets (ROA) ratio meanwhile is an indication of how profitable a company is relative to the total asset it owns. China Pharma Holdings Inc. (CPHI)’s ROA at the moment stands at -22.00%. Any company that is managing its assets better will have a higher return while one that manages assets poorly would result in low returns.
China Pharma Holdings Inc. (CPHI) has a return on investment (ROI) of -27.10%. The higher the ROI percentage, the higher the profit exceeds the costs, thus analysts consider such investments as an overall gain. A negative ROI, however, means that the cost is higher than the profits, a scenario analysts consider as a net loss.
Let us now take a look at China Pharma Holdings Inc. (CPHI)’s trading volatility. Its 7-day volatility is around 36.69%, while it has a monthly volatility of 24.83%. CPHI has an ATR (Average True Range) of 0.12 and a beta factor of 1.82. The volatility of a stock is an indication of the stock’s drop or gain in case the wider market drops or surges. A beta score higher than 1 means that a stock is highly volatile while below 1 means that the volatility of a stock is low.
The price of CPHI moved down by -$0.07 during the normal trading session on Thursday to trade at $0.52. The China Pharma Holdings Inc. (CPHI) stock has a trading volume of 1.86 million shares, which is high, compared to its average daily volume of 1.75M shares.